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Abstract
Introduction and hypothesis Our aim was to translate then
assess the reliability of the culturally adapted Pelvic Organ
Prolapse/Incontinence Sexual Function Questionnaire, Inter-
national Urogynecological Association (IUGA)-Revised
(PISQ-IR) to assess sexual health among Arabic-speaking
women with pelvic floor disorders.
Methods PISQ-IR was modified to consider cultural charac-
teristics of theMiddle East. The final reliability study included
172 women with urinary incontinence (UI) and/or pelvic or-
gan prolapse (POP). Participants completed the questionnaire
twice: at enrollment and 2 weeks later.
Results Among sexually active women, good internal consis-
tency was observed for five of the six scales in the adapted
instrument: Global Quality (Cronbach’s coefficient α=0.86),
Condition Impact (α=0.87), Desire (α=0.82), Condition Spe-
cific (α=0.74), and Partner Related (α=0.75). Internal consis-
tency was acceptable for the Arousal Orgasm subscale (α=
0.66). However, among not sexually active women, internal
consistency was poor (α <0.6) for all four scales. Lin’s concor-
dance correlation coefficient measuring agreement between test
and retest measurements [Lin’s concordance correlation coeffi-
cient (CCC); a value of 1 represents perfect agreement] ranged
from 0.81 to 0.87 for the not sexually active scales, except for
condition impact (CCC=0.63.) For sexually active women,
CCC was typically stronger, ranging from 0.85 to 0.96.
Conclusions PISQ-IR questionnaire is easy to administer and
reliable for assessing sexual function in sexually active Arabic
women with POP and UI, but internal consistency is poor for
Arabic women not sexually active.
Keywords Questionnaire . Quality of life . Prolapse . Sexual
dysfunction . Urinary incontinence . Fecal incontinence
Abbreviations
FSD Female sexual dysfunction
POP Pelvic organ prolapse
QoL Quality of life
PISQ-IR Pelvic Organ Prolapse Incontinence Sexual
Function Questionnaire, IUGA-Revised
IUGA International Urogynecological Association
UI Urinary incontinence
SA Sexually active
NSA Not sexually active
CCC Concordance Correlation Coefficient
Introduction
The Middle East in general and the Egyptian culture specifi-
cally are known for their conservative attitude toward sexual
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issues, especially for women. Sexual education is not
yet allowed in any form. Awareness of available methods for
treatment of female sexual dysfunction (FSD) is limited.
Availability of treatment for certain problems is still a chal-
lenge. Even in well-trained physicians, there is considerable
deficiency in adequate knowledge to treat FSD. FSD seems to
be a hidden but a major problem in the Middle East, and a
study that assessed 1,000 married women showed that the
prevalence of FSD is high, approaching 70% among the stud-
ied sample [1]. One study estimated the prevalence of urinary
incontinence (UI) in Egypt to be as high as 55 % [2]. Data on
the prevalence of genital prolapse are limited. Pelvic organ
prolapse (POP) in Egypt tends to occur at earlier ages due to
high parity rate and early age at marriage [3]. Data suggest
higher rates of sexual dysfunction among women with pelvic
floor disorders (PFD), including POP and UI [4].
To be used in clinical or research practice, a questionnaire
must demonstrate three important psychometric characteris-
tics: validity, reliability, and responsiveness (change with
treatment). A questionnaire that is valid and reliable for a
particular language and culture may not prove so when used
in a different population. Two important questionnaires have
been introduced into clinical practice to evaluate female sex-
ual dysfunction: the Female Sexual Function Index (FSFI),
and the McCoy Female Sexuality Questionnaire (MFSQ).
Both are designed to evaluate sexual function in a general
population and not specifically in women with PFD. Though
they are simple, easy to understand, reliable, and valid, they
do not address the unique sexual problems associated with
POP and how it affects quality of life (QoL). The only
condition-specific questionnaire to assess sexual function in
women with POP or UI is the Pelvic Organ Prolapse and
Incontinence Sexual Function Questionnaire (PISQ). The In-
ternational Urogynecological Association (IUGA) Sexual
Function Group revised and modified the original short ver-
sion of the questionnaire PISQ-12 (PISQ-IR i.e., IUGA-Re-
vised) with the aim to develop a condition-specific instrument
intended for international use and to assess sexual function in
women who are both sexually and not sexually active, as well
as women with fecal incontinence (FI). In addition, the PISQ-
IR was developed to evaluate women without a partner and
those who do not consider themselves to be sexually active.
The PISQ-IR also assesses the impact of the partner on a
woman’s sexual function [5]. The questionnaire is sensitive
to the unique aspects of FPFD on sexual function and how it
affects the life of the patient. The PISQ-IR is a valid and
reliable questionnaire and contains 20 items that assess six
domains: desire, arousal, orgasm, pain, partner, and condition
impact (POP/UI) [6]. Translation and adaptation of this instru-
ment for Arabic-speaking womenwill enable us to collect data
about an important and underrecognized condition in this pop-
ulation, especially because of cultural norms that discourage
discussion of these issues. The aim of this study was to
translate and adapt the PISQ-IR questionnaire and assess its
reliability to evaluate sexual health among Arabic-speaking
women with PFD.
Materials and methods
The study was approved by the Ethical Committee of the
University at the Asyut University Urology Hospital, Asyut,
Egypt.
PISQ-IR: description and adaptation
The PISQ-IR, a valid and reliable questionnaire and contains
20 items, is intended to be self-administered. If the woman
cannot read, the research nurse (RN) provides nondirective
assistance. The questionnaire is divided into two major parts:
the first part (Q2–6) is directed to womenwho are not sexually
active (NSA) and the second (Q7–20) to those who are sexu-
ally active (SA). The SA part consists of six subscales:
1. Arousal/orgasm: four items (Q7, 8a, 10, 11)
2. Partner-related issues: three items (Q13, 14a, 14b)
3. Condition-specific issues: three items (Q8a, 8b, 9)
4. Global quality: four items (Q19a, 19b, 19c, 20a)
5. Condition impact: four items (Q18, 20b, 20c, 20d)
6. Desire: three items (Q15, 16, 17)
The sexually inactive part consists of four domains:
1. Partner-related
2. Condition specific
3. Global quality
4. Condition impact [6]
Cultural adaptation
In the adaptation process, it was important to keep in mind the
cultural norms among Arabic-speaking women and thus nec-
essary to modify some items from the original questionnaire.
All questions specified sex to be practiced with the husband
only. For Q3, the phrase Bbulging in the vagina (either the
bladder, rectum or uterus….^ were not understood by our
patients and were replaced by the term vaginal prolapse.
Q12 was modified to inquire about the date of marriage, as
it would be culturally unacceptable to ask a woman if she has a
partner.
Linguistic validation
The aim was to translate the questionnaire into clear, easy to
understand, and conceptually equivalent to the original
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version [7]. This was accomplished in two steps: forward
translations and backward translation. The first consists of
translating the questionnaire into Arabic (target), which was
done by translators who are native Egyptian language
speakers and bilingual in the English language, thus produc-
ing two translations of the questionnaire into Arabic. The
study coordinator then discussed the translations with each
translator and all agreed on one version. That version was then
sent to the IUGA Research and Development (R&D) Com-
mittee and IUGA Sexual Function Group for final notes to
produce first version (V1).
Focus group (cognitive interview)
The questionnaire was administered to a group of pa-
tients with POP, FI, and/or UI attending the outpatient
Female Urology Clinic. The purpose was to discuss
each individual item in the questionnaire to make sure
that each question conveys the intent and meaning of
this question to participants. The interview assessed
whether the language used was simple and appropriate.
These interviews were conducted both in one-on-one
sessions (one patient only) and small focus groups
(two to four patients in each session) and comprised
eight women with POP and/or UI. During the inter-
views, the questionnaire was reported by all women to
be easy to understand and unambiguous. After that, the
final wordings were established for each question in the
instrument and a pooled version of the questionnaire
was completed (V2).
Back-translation
The V2 version of the questionnaire was translated back
into English. This back-translation was not done by the
original translators but by another, independent, transla-
tor. As recommended by the IUGA, the final translation
and the back-translation into English were submitted to
the IUGA Translation Working Group for review and
comparison of the backward version with the original
questionnaire.
Validation study
The questionnaire was administered to a group of women with
UI and/or POP symptoms to assess each the performance of
each item (internal consistency) and test–retest reliability.
Construct validity was assessed during development of the
original questionnaire and was not assessed in this study.
Women attending the Female Urology Outpatient Clinic,
Asyut University Urology Hospital, complaining of POP
and/or UI were invited to participate. This is the biggest ter-
tiary referral center in upper Egypt and receives patients of
different socioeconomic and educational levels. After
explaining the nature of the study, we obtained informed con-
sent; the questionnaire is intended to be self-administered. The
RN provided unassisted guidance to those who could not read
or write. As women in the Middle East are embarrassed to
disclose sensitive information about their sexual relationships,
they may feel more comfortable with a female RN. Evaluation
included complete history and physical examination, includ-
ing POP-Q staging. Women with vulvodynia, painful bladder
syndrome, chronic pelvic pain, and neurological deficit were
excluded. Women were then asked to come back to the clinic
after 2 weeks to complete the questionnaire again in order to
assess questionnaire stability over time.
Statistical analysis
PISQ-IR scale scoring for SA and NSA patients were calcu-
lated using transformed sum (scored as 0–100), and the scale
was set to missing if > 50 % of items was not answered, as
recommend by Rogers et al. [6] Thus, one missing was
allowed for scales with two or three items, and two missing
were allowed for scales with four items. The missing pattern
of each item in the questionnaire was examined. Internal con-
sistency is a measure of how well items in the same scale
correlate with each other as an indicator of whether these items
are measuring a similar concept, and the standardized
Cronbach’s coefficient α was calculated [8]. Patients who
completed the questionnaire twice, at baseline and again
after 2 weeks, were used for assessing test–retest reli-
ability. The difference between test and retest surveys in
the NSA and SA scales was first calculated, and the
paired t test was performed to identify significant dif-
ference between these repeated scores. The family-wise
error rate adjustment for multiple comparisons, based on
Hochberg’s method, was used Further, Lin’s concor-
dance correlation coefficient (CCC), which ranges
ranges from −1 to 1 with a value of 1 representing
complete agreement, was calculated [9]. As a second
measure of absolute/apparent reliability, we considered
whether absolute differences between test and retest
were > 10 %. We set a priori (before data analysis) that
differences between test and retest of no more than
10 % would be additional evidence of reliability, aug-
menting information provided by the concordance coef-
ficient. Analyses were performed using SAS 9.3 (Cary,
NC, USA).
Results
The final version of the questionnaire was administered to 172
patients (30 NSA and 142 SA). The basic characteristics of
study participants are summarized in Table 1. Predominantly,
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they had at most a primary school education (91.2%), and 7%
were diabetic. Diagnosis reported included 40.1 % SUI,
30.2 % urgency urinary incontinence (UUI), 26.2 % SUI plus
POP, and 3.5 % mixed urinary incontinence (MUI). Sixty-
eight percent reported no previous operation; 52.3 % had sur-
gery planned; 67.4 % were premenopausal. Vaginal delivery
was predominant (88.4 %), and most women reported no
medical disease (90.1 %).
Item response
Item nonresponse within each NSA and SA scale are summa-
rized in Table 2. For NSA, the response rate was 100 % for all
scales except for NSA-CS (condition specific), which had two
nonresponses from both the first (6.7 %) and second (7.4 %)
questionnaire administration. Since no participant missed
50 % of the items, all NSA scales were calculated from all
participants for both administrations. For the SA scale, the
nonresponse rate from the first administration was mostly <
10 % for items in SA-AO (arousal/orgasm), SA-CS, SA-GQ
(global quality), and SA-D (desire), and mostly > 10 % for
SA-PR (partner related) and SA-CI (condition impact). The
proportion of participants that responded to at least 50 % of
items were > 95 % for all but SA-PR (91.5 %). The nonre-
sponse rate of SA from the second administration was similar,
but the proportion > 50 % nonresponse items in SA-PR in-
creased to 14.4 %.
Internal consistency
Internal consistency, determined using Cronbach’s coefficient
α, for each scale is reported in Table 3. Good internal consis-
tency was observed for SA-GQ (α=0.86), SA-CI (α=0.87),
and SA-D (α=0.82), along with SA-CS (α=0.74) and SA-PR
(α=0.75); it was acceptable for SA-AO (α=0.66) and poor
for all NSA scales (α<0.6).
Test–retest reliability
The same questionnaire was administered again, 2 weeks
after initial administration, to 27 NSA and 90 SA wom-
en of the original cohort. Table 4 provides the differ-
ence and correlation between the wo repeated responses.
The mean difference of scales ranged from −1.0 to 3.3
for NSA women and −0.4 to 2.8 for SA women. The
difference between test and retest for all scale was not
significant. Moreover, CCC measuring concordance/
agreement ranged from 0.81 to 0.87 for NSA, except
for NSA-CI, with a CCC of only 0.63. CCC for SA
scales was typically stronger, ranging from 0.85 (for
SA-PR) to 0.96 (for the SA-CI). We also considered a
more strict criteria of apparent agreement, which is that the
difference between test and retest must be no more than 10 %
(Table 4). By this strict criteria, NSA-GQ scale had 85 %
agreement but the other three were low (44–52 %). For SA
scales, this apparent agreement was high, >72 %, except for
SA-PR (54 %).
Discussion
The most valid way of measuring the presence, severity, and
impact of sexual dysfunction on a patient’s activities and well-
being is through the use of psychometrically sound question-
naires. We describe the validation and adaptation of the PISQ-
IR as a condition-specific tool to assess sexual function of
women with PFDs. Validating these questionnaires allows
the study of and better treatment for Arabic-speaking women
with PFD, which is applicable in many countries around the
world. In addition, it will help to screen the minor group of
women who are hesitant to initiate talks about their sexual
concerns, especially in the conservative Middle Eastern com-
munity [10]. The IUGA committee previously validated the
questionnaire to different international cultures [6]. In this
study, we present our validation and cultural adaptation of
Table 1 Basic characteristics of study participants
N=172
Age, years (mean, SD) 43 (9.4)
Educational level
Illiterate 55.2 %
Primary school level 36.0 %
High school Level 6.4 %
College 2.3 %
Parity (median, range) 5 (0–10)
Mode of delivery
Vaginal 88.4 %
C section 3.5 %
Vaginal delivery plus C section 4.7 %
Nulliparous 3.5 %
Hormonal state
Premenopausal 67.4 %
Postmenopausal 32.6 %
Diagnosis
SUI 40.1 %
UUI 30.2 %
MUI 3.5 %
SUI and POP 26.2 %
Prolapse stage
Cystocele Stage II (mean Aa point 1.7 cm)
Rectocele Stage II (mean Ap point 1.2 cm)
standard deviation, C section cesarean secion, SUI stress urinary inconti-
nence, UUI urgency urinary incontinence, MUI mixed urinary inconti-
nence, POP pelvic organ prolapse
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the PISQ-IR for assessing sexual function in Arabic women
with POP or UI.
It was important to culturally adapt the questionnaire to the
intended community. Our PISQ-IR considered the unique cul-
tural circumstances of Middle Eastern women. Thus, it was
necessary to modify some items from the original question-
naire. Religion in the Middle East plays an important role in
shaping the health behavior of women; thus, all questions
specified sexual practice in the context of the husband–wife
relationship.
Our study confirmed that the PISQ-IR is a psychometrical-
ly sound instrument with good reliability for evaluating sexual
function among sexually active Arabic women with POP and/
or UI. The internal consistency was good for five of the six SA
scales (α 0.74–0.87) and acceptable for the arousal/orgasm
subscale (α=0.66). The test-–etest analysis showed the repeat
scores to be highly concordant for all scales (CCC>0.84), in-
dicating good overall agreement. Furthermore, our additional,
more strict, criteria of differences between test–retest measure-
ment of no more than 10 % also indicated good agreement for
Table 2 Nonresponses for each item for sexually active (SA) and not sexually active (NSA) scale
Item Scale First administration Second administration
Missing in
each item
Proportion of missing items in each scale Missing in
each item
Proportion of missing items in each scale
None ≤50 % >50 % None ≤50 % >50 %
Sexually inactive N=30 N=27
NSA-CS Q2c 0 28
(93.3 %)
2
(6.7 %)
0 0 (0.0 %) 25
(92.6 %)
2
(7.4 %)
0
Q2d 2 (6.7 %) 1 (3.7 %)
Q2e 0 1 (3.7 %)
NSA-PR Q2a 0 30
(100 %)
0 0 0 27
(100 %)
0 0
Q2b 0 0
NSA-GQ Q4a 0 30
(100 %)
0 0 0 27
(100 %)
0 0
Q4b 0 0
Q5a 0 0
Q6 0 0
NSA-CI Q3 0 30
(100 %)
0 0 0 27
(100 %)
0 0
Q5b 0 0
Q5c 0 0
Sexually active N=142 N=90
SA-AO Q7 1 (0.7 %) 131
(92.3 %)
11
(7.7 %)
0 0 86 (95.6 %) 4
(4.4 %)
0
Q8a 9 (6.3 %) 3 (3.3 %)
Q10 1 (0.7 %) 1 (1.1 %)
Q11 0 (0.0 %) 0
SA-CS Q8b 5 (3.5 %) 131
(92.3 %)
6
(4.2 %)
5
(3.5 %)
2 (2.2 %) 84
(93.3 %)
4
(4.4 %)
2
(2.2 %)Q8c 9 (6.3 %) 6 (6.7 %)
Q9 2 (1.4 %) 0
SA-PR Q13 17 (12.0 %) 101
(71.1 %)
29
(20.4 %)
12
(8.5 %)
7 (7.8 %) 68
(75.6 %)
9
(10.0 %)
13
(14.4 %)Q14a 15 (10.6 %) 16 (17.8 %)
Q14b 28 (19.7 %) 16 (17.8 %)
SA-GQ Q19a 13 (9.2 %) 117
(82.4 %)
19
(13.4 %)
6
(4.2 %)
6 (6.7 %) 72
(80.0 %)
16
(17.8 %)
2
(2.2 %)Q19b 11 (7.7 %) 1 (1.1 %)
Q19c 8 (5.6 %) 5 (5.6 %)
Q20a 16 (11.3 %) 13 (14.4 %)
SA-CI Q18 1 (0.7 %) 110
(77.5 %)
26
(18.3 %)
6
(4.2 %)
2 (2.2 %) 71
(78.9 %)
19
(21.1 %)
0
Q20b 22 (15.5 %) 9 (10.0 %)
Q20c 19 (13.4 %) 9 (10.0 %)
Q20d 16 (11.3 %) 6 (6.7 %)
SA-D Q15 7 (4.9 %) 124
(87.3 %)
14
(9.9 %)
4
(2.8 %)
4 (4.4 %) 79
(87.8 %)
11
(12.2 %)
0
Q16 7 (4.9 %) 3 (3.3 %)
Q17 10 (7.0 %) 4 (4.4 %)
NSA not sexually active, SA sexually active, CS condition specific,PR partner related, GQ global quality,CI condition impact, D desire
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the five scales (>72 %). The response rate was high, and wom-
en found the questionnaire easy to understand and quick and
easy to complete and interpret. However, among NSA Arabic
women with POP and/or UI, internal consistency was low for
all four NSA scales (α<0.6), even though concordance was
good for three scales (CCC>0.8).
Limitations of our study are that women with FI were not
included and the number of NSA women was small. We de-
veloped a culturally appropriate questionnaire that has
established reliability, but validity testing was not done. Fur-
thermore, because of the current lack of available tools to
assess FSD in Arabic women, our results will strengthen in
future studies in which the PISQ-IR is compared/correlated
with other measurements for sexual function or pelvic floor
dysfunction for Arabic women.
Conclusion
Our preliminary findings indicate that the PISQ-IR is a psy-
chometrically sound instrument with good test–retest reliabil-
ity for evaluating sexual function among sexually active Ara-
bic women with POP and/or UI; however, for sexually inac-
tive Arabic women, internal consistency is poor.
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Appendix
Pelvic Organ Prolapse/Incontinence Sexual Questionnaire,
IUGA-Revised (PISQ-IR): Sexual function for women with
pelvic organ prolapse, urinary Incontinence, and/or fecal
incontinence
Q1 Which of the following best describes you?
a. Not sexually active at all → Go to item Q2 - Not
Active Section
b. Sexually active normally with husband→ Go to item
Q7 - Sexually Active Section
Sexualy inactive section (Q2 thru 6)
Q2 The following are reasons why you might not be sexu-
ally active with your husband. For each one, please
Table 3 Mean transformed sum score and Cronbach’s coefficient α for
each scale
Scale No. Transformed sum
score (mean±SD)
Standardized
Cronbach’s
coefficient α
NSA-CS 30 48.7±17.6 <0
NSA-PR 30 41.0±29.8 0.40
NSA-GQ 30 70.9±15.9 0.59
NSA-CI 30 58.9±21.3 0.47
SA-AO 142 47.3±17.1 0.66
SA-CS 137 65.8±22.3 0.74
SA-PR 130 66.8±20.6 0.75
SA-GQ 136 55.9±26.2 0.86
SA-CI 136 55.8±30.0 0.87
SA-D 138 52.6±21.6 0.82
NSA not sexually active, SA sexually active, CS condition specific,PR
partner related, GQ global quality,CI condition impact, D desire
Table 4 Test–retest reliability
Scale No. Difference
(second vs first)
(mean±SD
Lin’s concordance
correlation
coefficient
Acceptable
agreement
(absolute
difference
≤10 %); N (%)
NSA-CS 27 −1.0±11.7 0.81 13 (48.1 %)
NSA-PR 27 3.1±14.6 0.87 12 (44.4 %)
NSA-GQ 27 −0.2±8.1 0.83 23 (85.2 %)
NSA-CI 27 0.9±18.4 0.63 14 (51.9 %)
SA-AO 90 −0.4±7.3 0.90 77 (85.6 %)
SA-CS 86 1.4±9.5 0.89 70 (81.4 %)
SA-PR 76 2.2±11.7 0.85 41 (53.9 %)
SA-GQ 85 1.1±10.3 0.87 64 (75.3 %)
SA-CI 85 2.8±10.7 0.96 62 (72.9 %)
SA-D 87 2.4±12.0 0.87 72 (82.8 %)
NSA not sexually active, SA sexually active, CS condition specific,PR
partner related, GQ global quality,CI condition impact, D desire
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indicate how strongly your agree or disagree with it as a
reason that you are not sexual active
Q3 How much does the fear of leaking urine and/or stool
and/or a bulging in the vagina (either the bladder, rec-
tum, or uterus falling out) cause you to avoid or restrict
your sexual activity?
1. Not at all
2. A little
3. Some
4. A lot
Q4 For each of the following, please circle the number be-
tween 1 and 5 that best represents how you feel about
your sex life.
RATING
a. Satisfied 1 2 3 4 5 Dissatisfied
b. Adequate 1 2 3 4 5 Inadequate
Q5 How strongly do you agree or disagree with each of the
following statements:
Q6 Overall, how bothersome is it to you that you are not
sexually active?
1. Not at all
2. A little
3. Some
4. A lot
Sexually active section (Q7–20)
Q7 How often do you feel sexually aroused (physically excit-
ed or turned on) during sexual activity with your husband:
1. Never
2. Rarely
3. Sometimes
4. Usually
5. Always
Q8 When you are involved in sexual activity, how often do
you feel each of the following?
NEVER RARELY SOMETIMES USUALLY ALMOST
ALWAYS
a. Fulfilled 1 2 3 4 5
c. Shame 1 2 3 4 5
d. Fear 1 2 3 4 5
Q9 How often do you leak urine and/or stool with any type
of sexual activity?
1. Never
2. Rarely
3. Sometimes
STRONGLY
AGREE
SOMEWHAT
AGREE
SOMEWHAT
DISAGREE
STRONGLY
DISAGREE
a. Husband absent (traveling, divorced, passed away) 1 2 3 4
b. No Interest 1 2 3 4
c. Due to bladder or bowel problems (urinary or fecal incontinence) or due to prolapse 1 2 3 4
d. Because of my other health problems 1 2 3 4
e. Pain 1 2 3 4
STRONGLY
AGREE
SOMEWHAT
AGREE
SOMEWHAT
DISAGREE
STRONGLY
DISAGREE
a. I feel frustrated by my sex life 1 2 3 4
b. I feel sexually inferior because of my incontinence and/or prolapse 1 2 3 4
c. I feel angry because of the impact that incontinence and/or prolapse has on my sex life 1 2 3 4
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4. Usually
5. Always
Q10 Compared to orgasms you have had in the past, how
intense are your orgasms now?
1. Much less intense
2. Less intense
3. Same intensity
4. More intense
5. Much more intense
Q11 How often do you feel pain during sexual intercourse?
1. Never
2. Rarely
3. Sometimes
4. Usually
5. Always
Q12 What is the duration of your marriage?
Q13 How often does your husband have a problem during
sexual intercourse (lack of arousal, desire, erection,
etc.) that limits your sexual activity?
1. All of the time
2. Most of the time
3. Some of the time
4. Hardly ever/rarely
Q14 In general, would you say that your husband has a
positive or negative impact on each of the following:
Q15 When you are involved in sexual activity with your
husband, how often do you feel that you want more?
1. Never
2. Rarely
3. Sometimes
4. Usually
5. Always
Q16 How frequently do you have sexual desire? This may
include wanting to have sex, having sexual thoughts or
fantasies, etc.
1. Daily
2. Weekly
3. Monthly
4. Less often than once a month
5. Never
Q17 How would you rate your level (degree) of sexual de-
sire or interest?
1. Very high
2. High
3. Moderate
4. Low
5. Very low or none at all
Q18 How much does the fear of leaking urine, stool, and/or
a bulging in the vagina (prolapse) cause you to avoid
sexual activity?
1. Not at all
2. A little
3. Some
4. A lot
Q19 For each of the following, please circle the number
between 1 and 5 that best represents how you feel about
your sex life.
RATING
a. Satisfied 1 2 3 4 5 Dissatisfied
b. Adequate 1 2 3 4 5 Inadequate
c. Confident 1 2 3 4 5 Not confident
Q20 How strongly do you agree or disagree with each of the
following statements:
STRONGLY
AGREE
SOMEWHAT
AGREE
SOMEWHAT
DISAGREE
STRONGLY
DISAGREE
a. I feel frustrated by my sex life 1 2 3 4
b. I feel sexually inferior because of my incontinence and/or prolapse 1 2 3 4
c. I feel embarrassed about my sex life 1 2 3 4
d. I feel angry because of the impact that incontinence and/or prolapse has on my sex life 1 2 3 4
VERY
POSITIVE
SOMEWHAT
POSITIVE
SOMEWHAT
NEGATIVE
VERY
NEGATIVE
a. Your
sexual desire
1 2 3 4
b. The frequency
of your sexual
activity
1 2 3 4
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